M. René Bouw

956 total citations
16 papers, 741 citations indexed

About

M. René Bouw is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Psychiatry and Mental health. According to data from OpenAlex, M. René Bouw has authored 16 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 7 papers in Oncology and 6 papers in Psychiatry and Mental health. Recurrent topics in M. René Bouw's work include Pharmacological Effects and Toxicity Studies (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Epilepsy research and treatment (4 papers). M. René Bouw is often cited by papers focused on Pharmacological Effects and Toxicity Studies (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Epilepsy research and treatment (4 papers). M. René Bouw collaborates with scholars based in United Kingdom, United States and Sweden. M. René Bouw's co-authors include Margareta Hammarlund‐Udenaes, Rujia Xie, Elizabeth C. M. de Lange, Karin Tunblad, Meindert Danhof, J. Ives, Ulrika Wählby, Mats O. Karlsson, E. Niclas Jonsson and Mark D. Pescovitz and has published in prestigious journals such as British Journal of Pharmacology, Pharmaceutical Research and American Journal of Transplantation.

In The Last Decade

M. René Bouw

16 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. René Bouw United Kingdom 15 235 231 172 167 149 16 741
Pascal André Switzerland 19 249 1.1× 216 0.9× 133 0.8× 156 0.9× 168 1.1× 41 1.1k
Daniël M. Jonker Denmark 10 180 0.8× 98 0.4× 54 0.3× 152 0.9× 142 1.0× 19 890
Klaas P. Zuideveld Netherlands 15 89 0.4× 183 0.8× 152 0.9× 57 0.3× 67 0.4× 19 810
Lauren Walker United Kingdom 13 120 0.5× 108 0.5× 80 0.5× 149 0.9× 65 0.4× 38 773
Vijay Ivaturi United States 16 175 0.7× 105 0.5× 82 0.5× 152 0.9× 119 0.8× 51 788
R. K. Nayak United States 16 406 1.7× 123 0.5× 133 0.8× 435 2.6× 280 1.9× 26 986
Linda E. Gustavson United States 17 284 1.2× 119 0.5× 72 0.4× 285 1.7× 86 0.6× 23 722
Helga Flachs Denmark 17 359 1.5× 93 0.4× 89 0.5× 276 1.7× 62 0.4× 43 999
Herbert Kurz Austria 18 160 0.7× 101 0.4× 106 0.6× 52 0.3× 115 0.8× 68 952
Martine Monnat Switzerland 11 176 0.7× 107 0.5× 71 0.4× 56 0.3× 93 0.6× 23 697

Countries citing papers authored by M. René Bouw

Since Specialization
Citations

This map shows the geographic impact of M. René Bouw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. René Bouw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. René Bouw more than expected).

Fields of papers citing papers by M. René Bouw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. René Bouw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. René Bouw. The network helps show where M. René Bouw may publish in the future.

Co-authorship network of co-authors of M. René Bouw

This figure shows the co-authorship network connecting the top 25 collaborators of M. René Bouw. A scholar is included among the top collaborators of M. René Bouw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. René Bouw. M. René Bouw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bouw, M. René, et al.. (2021). Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray. Epilepsy Research. 171. 106567–106567. 22 indexed citations
2.
Edeki, Timi, et al.. (2015). Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime–avibactam in healthy Japanese volunteers. Journal of Infection and Chemotherapy. 21(8). 551–558. 31 indexed citations
3.
Pescovitz, Mark D., Robert B. Ettenger, C. Frederic Strife, et al.. (2009). Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients. Transplant Infectious Disease. 12(3). 195–203. 48 indexed citations
4.
Varela‐Fascinetto, Gustavo, et al.. (2009). Valganciclovir Dosing According to Body Surface Area and Renal Function in Pediatric Solid Organ Transplant Recipients. American Journal of Transplantation. 9(3). 636–643. 81 indexed citations
5.
Pescovitz, Mark D., Stuart J. Knechtle, Steven R. Alexander, et al.. (2007). Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients. Pediatric Transplantation. 12(4). 447–455. 21 indexed citations
6.
7.
Pescovitz, Mark D., Flavio Vincenti, Marquis Hart, et al.. (2007). Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients. British Journal of Clinical Pharmacology. 64(6). 758–771. 20 indexed citations
8.
Pescovitz, Mark D., et al.. (2007). Establishing Pharmacokinetic Bioequivalence of Valganciclovir Oral Solution Versus the Tablet Formulation. Transplantation Proceedings. 39(10). 3111–3116. 21 indexed citations
9.
Freijer, Jan, et al.. (2007). Influence of biophase distribution and P‐glycoprotein interaction on pharmacokinetic‐pharmacodynamic modelling of the effects of morphine on the EEG. British Journal of Pharmacology. 151(5). 713–720. 19 indexed citations
10.
Wählby, Ulrika, M. René Bouw, E. Niclas Jonsson, & Mats O. Karlsson. (2002). Assessment of Type I Error Rates for the Statistical Sub-model in NONMEM. Journal of Pharmacokinetics and Pharmacodynamics. 29(3). 251–269. 56 indexed citations
11.
Bouw, M. René, Rujia Xie, Karin Tunblad, & Margareta Hammarlund‐Udenaes. (2001). Blood‐brain barrier transport and brain distribution of morphine‐6‐glucuronide in relation to the antinociceptive effect in rats – pharmacokinetic/pharmacodynamic modelling. British Journal of Pharmacology. 134(8). 1796–1804. 80 indexed citations
12.
Xie, Rujia, M. René Bouw, & Margareta Hammarlund‐Udenaes. (2000). Modelling of the blood‐brain barrier transport of morphine‐3‐glucuronide studied using microdialysis in the rat: involvement of probenecid‐sensitive transport. British Journal of Pharmacology. 131(8). 1784–1792. 51 indexed citations
13.
14.
Bouw, M. René. (2000). Microdialysis as a tool in pharmacokinetic-pharmacodynamic studies investigating the brain distribution and effect delay of morphine and morphine-6-glucuronide. 1 indexed citations
15.
Bouw, M. René & Margareta Hammarlund‐Udenaes. (1998). Methodological Aspects of the Use of a Calibrator in In Vivo Microdialysis–Further Development of the Retrodialysis Method. Pharmaceutical Research. 15(11). 1673–1679. 108 indexed citations
16.
Lange, Elizabeth C. M. de, M. René Bouw, Jaap W. Mandema, et al.. (1995). Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain. British Journal of Pharmacology. 116(5). 2538–2544. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascal André Breakdown of academic impact, for papers by Daniël M. Jonker Breakdown of academic impact, for papers by Klaas P. Zuideveld Breakdown of academic impact, for papers by Lauren Walker Breakdown of academic impact, for papers by Vijay Ivaturi Breakdown of academic impact, for papers by R. K. Nayak Breakdown of academic impact, for papers by Linda E. Gustavson Breakdown of academic impact, for papers by Helga Flachs Breakdown of academic impact, for papers by Herbert Kurz Breakdown of academic impact, for papers by Martine Monnat
Rankless by CCL
2026